Glenmark Pharmaceuticals accelerates U.S. strategy with direct RYALTRIS distribution
This marks a meaningful step in the company's continued expansion in the region
This marks a meaningful step in the company's continued expansion in the region
Certification by TÜV SÜD Product Service GmbH reinforces the company's commitment to globally benchmarked standards in safety, quality, and performance
Eylea 2mg (intravitreal aflibercept injection) is an anti-VEGF therapy that blocks a protein responsible for abnormal blood vessel growth and leakage in the retina
The program, which has been active for over a decade, will now expand its reach, focusing on equitable access to education, resources, and community-driven solutions for patients and care partners
The showcase, running March 27–31, puts a spotlight on everything from fine lines to daily sun protection
The partnership will focus on advancing fault-tolerant quantum algorithms and developing clinically relevant quantum applications
The framework introduces 15 consensus terms and definitions grouped across four core dimensions of skin health
Industry leaders highlighted the pharmaceutical sector’s role in advancing research, innovation, early screening, and multi-stakeholder collaboration
Huwel’s diagnostic solutions leverage open RT-PCR system
Subscribe To Our Newsletter & Stay Updated